在阿尔茨海默氏病中β-粉样酸化的特点
P A Strelnikova1,2, A E Bugrova1,2, N V Zakharova1,2
1Skolkovo Institute of Science and Technology, Moscow, 121205 Russian Federation.
Acta naturae
|November 18, 2024
概括
这项研究表明,化β-粉样蛋白 (pSer8-Aβ) 在阿尔茨海默氏症中积累.
科学领域:
- 神经科学是一个神经科学.
- 生物化学 生物化学
- 病理学 病理学 病理学
背景情况:
- 阿尔茨海默病 (AD) 的特点是β-粉样蛋白 (Aβ) 总积累.
- Aβ的翻译后修饰 (PTMs) 增强聚合和神经毒性.
- 在AD老年斑块中,特定的Aβ蛋白质形式升高,需要进一步研究.
研究的目的:
- 研究酸化氨酸-8Aβ (pSer8-Aβ) 的积累动态.
- 检查pSer8-Aβ蛋白质形式在阿尔茨海默氏病的发病过程中的作用.
- 在小鼠模型和人类样本中分析Aβ酸化.
主要方法:
- 利用5xFAD小鼠模型进行阿尔茨海默病研究.
- 使用1E4E11和4G8抗体的西方斑点分析.
- 对大脑组织和人类脑脊液 (CSF) 进行质谱.
主要成果:
- 鼠标大脑中的pSer8-Aβ积累开始于3个月,在14-17个月达到顶峰.
- 在AD患者的脑脊髓中,pSer8-Aβ水平约占总Aβ的1-10%.
- 在大脑组织中确定了Aβ (Ser8,Tyr10,Ser26) 和APP (Thr719) 上的酸化位.
结论:
- 在5xFAD小鼠模型中,pSer8-Aβ蛋白质形式与总Aβ一起积累.
- 有证据表明pSer8-Aβ蛋白质形式与阿尔茨海默氏症的amyloidosis有关.
- Aβ和APP的酸化是AD病理生理学的潜在贡献者.
相关概念视频
Amyloid Fibrils
9.3K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.3K
Phosphorylation
50.0K
The addition or removal of phosphate groups from proteins is the most common chemical modification that regulates cellular processes. These modifications can affect the structure, activity, stability, and localization of proteins within cells as well as their interactions with other proteins.
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
50.0K
Alzheimer's Disease: Overview
448
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
448
Alzheimer's Disease: Treatment
165
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
165
Protein Kinases and Phosphatases
13.1K
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
13.1K


